Insights provides context and perspective about key pharmacy trends and issues

Drug Pipeline
Biosimilars in the Autoimmune Category More
Briefing
Drug Pipeline
New Treatments for Alopecia Areata on the Horizon More
Briefing
Drug Pipeline
What's Next for Hemophilia Therapy and New Treatment Options? More
Briefing
Drug Pipeline
New Drugs for Ophthalmic Disorders on the Horizon More
Briefing
Drug Pipeline
Teplizumab: Potential Breakthrough Therapy for Type 1 Diabetes More
Briefing
Drug Pipeline
A Q2 2022 Look at Projected Gene Therapies and FDA Approval Timelines More
Briefing
Drug Pipeline
New Gene Therapies for Sickle Cell Disease, Hemophilia on the Horizon More
Briefing
Drug Pipeline
As more treatments for inflammatory bowel disease are approved, payors can counter cost increases with comprehensive utilization management. More
Briefing
Drug Pipeline
2022 Marketplace Outlook: Expanding Therapies, Indications and Implications for Payors More
Briefing
Drug Pipeline
Breakthrough Therapies and New Biologics Feature in the Gene Therapy Pipeline More
Briefing